title: Current trends in transplantation and immunosuppressive treatment.
abstract: The American Society of Transplant Surgeons and the American Society of Transplantation jointly sponsored their third American Transplant Congress on May 30-June 4, 2003. The meeting, which took place in Washington, D.C., U.S.A., thoroughly reviewed the different immunosuppressive protocols for every kind of transplantation. Also presented were the immunological and nonimmunological factors influencing the success or failure of transplants from the point of view of genetics, the place of new investigative agents and the current status of various therapeutic protocols intended to induce tolerance or normal function of grafts in the absence of immunosuppressive treatment. Presentations on renal, liver, heart, lung, multivisceral and islet transplantation are covered in this report, as well as aspects of new immunosuppressive agents, genomics in transplantation and tolerance induction in allotransplantation.
authors.affiliation: Transplantation Medicine and Xenotransplantation, Complexo Hospitalario Juan Canalejo, Xubias de Arriba 84, 15006 A Coruna, Spain. manez@canalejo.org
authors.forename: Rafael
authors.initials: R
authors.lastname: Manez
mesh_terms: D000577:Amides / Q000627:therapeutic use; D001577:Benzophenones / Q000627:therapeutic use; D001596:Benzylamines / Q000627:therapeutic use; D023281:Genomics; D006146:Guanidines / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000639:trends*; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007422:Intestines / Q000276:immunology / Q000637:transplantation; D016381:Islets of Langerhans Transplantation / Q000276:immunology; D053616:Janus Kinase 3; D016030:Kidney Transplantation / Q000276:immunology / Q000639:trends; D016031:Liver Transplantation / Q000276:immunology; D016040:Lung Transplantation / Q000276:immunology; D008715:Methionine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016377:Organ Transplantation / Q000639:trends*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000187:drug effects; D014184:Transplantation, Homologous / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000187:drug effects
chemical_list: C481646:A 228839; D000577:Amides; D001577:Benzophenones; D001596:Benzylamines; C481645:GENZ 29155; D006146:Guanidines; D007166:Immunosuppressive Agents; C434185:LF 150195; D014409:Tumor Necrosis Factor-alpha; D008715:Methionine; D011505:Protein-Tyrosine Kinases; C507933:JAK3 protein, human; D053616:Janus Kinase 3